San Diego CRO named as finalist for 2016 Scrip Awards Best CRO – Niche Providers!


Local CRO, Tioga Research, was shortlisted earlier this month as a 2016 Scrip Award finalist for the category of Best CRO – Niche Providers. The Scrip Awards have been acknowledging the hard work and innovation of pharmaceutical, biotech and supporting industries for over a decade. The awards comprise 14 categories spanning various aspects of organizational […]

Read More

August 31, 2016- Ins and outs of Patient Derived Xenograft (PDX): an important tool for preclinical cancer drug discovery

Ins and Outs of Patient Derived Xenograft (PDX): An Important Tool for Preclinical Cancer Drug Discovery With PDX models becoming more and more popular in preclinical cancer research, it’s prime time to explore the topic. Have you considered using PDX models in your preclinical cancer research? What are the challenges and the advantages? What are […]

Read More

Tomorrow….Outsourced Pharma West Conference

The highly anticipated Outsourced Pharma Conference & Exhibition will be taking place later this week in San Diego at the Hyatt Regency La Jolla. The two-day conference series began with its flagship event in 2014 in the California Bay Area and aims to address and promote outsourcing within the pharmaceutical and biotechnology industries. The conferences […]

Read More

Genea Biocells promotes awareness and funding for Friends of FSH Research.

Myotube Mike crusading for Friends of FSH research

Genea Biocells promotes awareness and funding for Friends of FSH Research.   Facioscapulohumeral Dystrophy (FSHD) affects hundreds of thousands of people worldwide with progressive loss of skeletal muscle strength affecting mainly the face, arms and legs. Scientists have only recently elucidated the pathogenesis that leads to this skeletal muscle weakness but much more research is […]

Read More

San Diego CRO Selected as 2016 Red Herring North America Top 100 Finalist


The critical role that contract research organizations (“CRO”s) can play in the development and ultimate commercialization of new pharmaceutical and biological products is universally appreciated. But, from a business perspective, the steady, typically linear growth of a successful CRO is less glamorous that the potential ‘hockey stick’ escalation in the value of a product company […]

Read More